Targeting cryopreservation-induced cell death: A review

Biopreservation and Biobanking

Volumn 12, Issue 1, 2014, Pages 23-34

  Bissoyi, A ^a   Nayak, Bismita ^a   Pramanik, K ^a   Sarangi, Sunil K ^a  

^a NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL DEATH; CELL SURVIVAL; CRYOPRESERVATION; HUMANS; MICE; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84894490111     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2013.0032     Document Type: Review

References (154)

1. Heo YJ, Son CH, Chung JS, Park YS, Son JH. The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy. Cryobiology 2009; 58:203-209.
2. Liu G, Zhou H, Li Y, et al. Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose- derived stem cells. Cryobiology 2008;57:18-24.
3. Terry C, Dhawan A, Mitry RR, Lehec SC, Hughes RD. Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transplant 2010;16:229-237.
4. Walbrun P, Hellerbrand C, Weiss TS, et al. Characterization of rat and human Kupffer cells after cryopreservation. Cryobiology 2007;54:164-172.
5. Wang S, Zhang W, Zhao J, et al. Long-term outcome of cryopreserved bone-derived osteoblasts for bone regeneration in vivo. Biomaterials 2011;32:4546-4555.
6. Heng BC, Ye CP, Liu H, et al. Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. J Biomed Sci 2006;13:433-445.
7. Nagle WA, Soloff BL, Moss AJ, Jr, Henle KJ. Cultured Chinese hamster cells undergo apoptosis after exposure to cold but nonfreezing temperatures. Cryobiology 1990;27: 439-451.
8. Baust JM, Van Buskirk R, Baust JG. Cell viability improves following inhibition of cryopreservation-induced apoptosis. In vitro Cell Devel Biol Animal 2000;36: 262-270.
9. Searle J, Kerr JF, Bishop CJ. Necrosis and apoptosis: Distinct modes of cell death with fundamentally different significance. Pathol Ann 1982;17:229-259.
10. Walker NI, Harmon BV, Gobe GC, Kerr JF. Patterns of cell death. Methods Achievements Exp Pathol 1988;13: 18-54.
11. Kerr JF. Shrinkage necrosis of adrenal cortical cells. J Pathol 1972;107:217-219.
12. Columbano A. Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 1995;58:181-190.
13. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
14. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
15. Trump B.F, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: Oncosis, apoptosis, and necrosis. Toxicol Pathol 1997;25:82-88.
16. Baust JM, Vogel MJ, Van Buskirk R, Baust JG. A molecular basis of cryopreservation failure and its modulation to improve cell survival. Cell Transplant 2001;10: 561-571.
17. Peter ME, Heufelder AE, Hengartner MO. Advances in apoptosis research. Proc Natl Acad Sci USA 1997;94: 12736-12737.
18. Gewirtz DA. Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage. Breast Cancer Res Treatment 2000;62:223-235.
19. Fink KB, Andrews LJ, Butler WE, et al. Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 1999;94: 1213-1218.
20. Emery E, Aldana P, Bunge MB, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998;89: 911-920.
21. Elsasser A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 2000;32:711-724.
22. Brune B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998;351:261-272.
23. Saikumar P, Dong Z, Weinberg JM, Venkatachalam MA. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998;17:3341-3349.
24. Liu CY, Liu YH, Lin SM, et al. Apoptotic neutrophils undergoing secondary necrosis induce human lung epithelial cell detachment. J Biomed Sci 2003;10: 746-756.
25. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003;125:1246-1257.
26. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997;91:443-446.
27. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998;281:1312-1316.
28. Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 2005;22:355-370.
29. Rai NK, Tripathi K, Sharma D, Shukla VK. Apoptosis: A basic physiologic process in wound healing. Intl J Lower Extremity Wounds 2005;4:138-144.
30. Adams JM. Ways of dying: Multiple pathways to apoptosis. Genes Devel 2003;17:2481-2495.
31. Bratton DL, Fadok VA, Richter DA, et al. Appearance of phosphatidylserine on apoptotic cells requires calciummediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997; 272:26159-26165.
32. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-1556.
33. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000;243: 167-190.
34. Chicheportiche Y, Bourdon PR, Xu H, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997;272: 32401-32410.
35. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305-1308.
36. Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/ Fas)-mediated apoptosis. Curr Opin Immunol 1998;10: 545-551.
37. Suliman A, Lam A, Datta R, Srivastava RK. Intracellular mechanisms of TRAIL: Apoptosis through mitochondrialdependent and -independent pathways. Oncogene 2001; 20:2122-2133.
38. Rubio-Moscardo F, Blesa D, Mestre C, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood 2005;106:3214-3222.
39. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-Associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995;81:495-504.
40. Wajant H. The Fas signaling pathway: More than a paradigm. Science 2002;296:1635-1636.
41. Boldin MP, Varfolomeev EE, Pancer Z, et al. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem1995;270:7795-7798.
42. Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicitydependent APO-1 (Fas/CD95)-Associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995;14:5579-5588.
43. Bodmer JL, Holler N, Reynard S, et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biol 2000;2:241-243.
44. Salvesen GS. Caspases and apoptosis. Essays Biochem 2002;38:9-19.
45. Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene 2008;27:6194-6206.
46. Kataoka T, Schroter M, Hahne M, et al. FLIP prevents apoptosis induced by death receptors but not by perforin/ granzyme B, chemotherapeutic drugs, and gamma irradiation. J Immunol 1998;161:3936-3942.
47. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999;274:1541-1548.
48. Saelens X, Festjens N, Vande Walle L, et al. Toxic proteins released from mitochondria in cell death. Oncogene 2004;23:2861-2874.
49. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102:33-42.
50. Garrido C, Galluzzi L, Brunet M, et al. Mechanisms of cytochrome c release from mitochondria. Cell Death Different 2006;13:1423-1433.
51. Li W, Srinivasula SM, Chai J, et al. Structural insights into the pro-Apoptotic function of mitochondrial serine protease HtrA2/Omi. Nature Structural Biology 2002;9: 436-441.
52. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005;55: 178-194.
53. Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; An update. Apoptosis 2003;8:115-128.
54. Chinnaiyan AM. The apoptosome: Heart and soul of the cell death machine. Neoplasia 1999;1:5-15.
55. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ. Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 2004;23: 2134-2145.
56. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
57. van Loo G, Saelens X, van Gurp M, et al. The role of mitochondrial factors in apoptosis: A Russian roulette with more than one bullet. Cell Death Different 2002;9:1031-1042.
58. Schimmer AD. Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice. Cancer Res 2004; 64:7183-7190.
59. Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): A phylogenetically old, caspaseindependent effector of cell death. Cell Death Different 1999;6:516-524.
60. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412:95-99.
61. Enari M, Sakahira H, Yokoyama H, et al. A caspaseactivated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50.
62. Joza N, Susin SA, Daugas E, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001;410:549-554.
63. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother CII 2004;53: 153-159.
64. Pluquet O, Hainaut P. Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett 2001;174:1-15.
65. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001;7:683-694.
66. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nature Cell Biology 2004;6: 443-450.
67. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003;11: 577-590.
68. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.
69. Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Biochem Soc Transact 2001;29:684-688.
70. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005; 103;1551-1560.
71. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol 2000;1:489-495.
72. Boone E, Vanden Berghe T, Van Loo G, et al. Structure/ Function analysis of p55 tumor necrosis factor receptor and fas-Associated death domain. Effect on necrosis in L929sA cells. J Biol Chem 2000;275:37596-37603.
73. Eliasson MJ, Sampei K, Mandir AS, et al. Poly(ADPribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med 1997;3:1089-1095.
74. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999;96:13978-13982.
75. Yoshioka A, Yamaya Y, Saiki S, et al. Non-N-methyl-Daspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury. Brain Res 2000;854:207-215.
76. Goossens V, De Vos K, Vercammen D, et al. Redox regulation of TNF signaling. Biofactors 1999;10:145-156.
77. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 1999;18:7719-7730.
78. Shimizu S, Eguchi Y, Kamiike W, et al. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 1996;12:2045-2050.
79. Brocheriou V, Hagege AA, Oubenaissa A, et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med 2000;2:326-333.
80. Tan J, Town T, Placzek A, et al. Bcl-X(L) inhibits apoptosis and necrosis produced by Alzheimer's betaamyloid1- 40 peptide in PC12 cells. Neurosc Lett 1999; 272:5-8.
81. Single B, Leist M, Nicotera P. Differential effects of bcl-2 on cell death triggered under ATP-depleting conditions. Exp Cell Res 2001;262:8-16.
82. Vande Velde C, Cizeau J, Dubik D, et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000;20:5454-5468.
83. Gabai VL, Meriin AB, Yaglom JA, et al. Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stewss-induced inhibition of JNK dephosphorylation. J Biol Chem 2000;275:38088-38094.
84. Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen- Activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999;99: 1685-1691.
85. Mochizuki T, Asai A, Saito N, et al. Akt protein kinase inhibits non-Apoptotic programmed cell death induced by ceramide. J Biol Chem 2002;277:2790-2797.
86. Matsui T, Tao J, del Monte F, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001; 104:330-335.
87. Punn A, Mockridge JW, Farooqui S, Marber MS, Heads RJ. Sustained activation of p42/p44 mitogen-Activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Biochem J 2000;350:891-899.
88. Yue TL, Wang C, Gu JL, et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenationinduced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circulation Res 2000;86:692-699.
89. Festjens N, Tom VB, Peter V. Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta Bioenergetics 2006;1757:1371-1387.
90. Wang Y, Singh R, Massey AC, et al. Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J Biol Chem 2008;283: 4766-4777.
91. Thorburn A. Apoptosis and autophagy: Regulatory connections between two supposedly different processes. Apoptosis 2008;13:1-9.
92. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000;19: 5720-5728.
93. Baust JG, Dayong Gao, Baust JM. Cryopreservation: An emerging paradigm change. Organogenesis 2009;3:90-96.
94. Baust JM. Three properties of cells and tissues influencing preservation outcome: Molecular basis of preservationinduced cell death. Adv Biopreserv 2010;63.
95. Baust JM, Snyder KK, VanBuskirk RG, Baust JG. Changing paradigms in biopreservation. Biopreserv Biobanking 2009;7:3-12.
96. Fu T, Guo D, Huang X, et al. Apoptosis occurs in isolated and banked primary mouse hepatocytes. Cell Transplant 2001;10:59-66.
97. de Boer F, Drager AM, Pinedo HM, et al. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002;29:249-255.
98. Xiao M, Dooley DC. Assessment of cell viability and apoptosis in human umbilical cord blood following storage. J Hematother Stem Cell Res 2003;12:115-122.
99. Paasch U, Grunewald S, Agarwal A, Glandera HJ. Activation pattern of caspases in human spermatozoa. Fertil Steril 2004;81:802-809.
100. Men H, Monson RL, Parrish JJ, Rutledge JJ. Degeneration of cryopreserved bovine oocytes via apoptosis during subsequent culture. Cryobiology 2003;47:73-81.
101. Schuurhuis GJ, Muijen MM, Oberink JW, et al. Large populations of non-clonogenic early apoptotic CD34- positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplant 2001;27:487-498.
102. Heng BC, Ye CP, Liu H, et al. Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. J Biomed Sci 2006;13:433-445.
103. Schmidt-Mende J, Hellstrom-Lindberg E, Joseph B, Zhivotovsky B. Freezing induces artificial cleavage of apoptosis- related proteins in human bone marrow cells. J Immunol Methods 2000;245:91-94.
104. Paasch U, Sharma RK, Gupta AK, et al. Cryopreservation and thawing is associated with varying extent of activation of apoptotic machinery in subsets of ejaculated human spermatozoa. Biol Reprod 2004;71:1828-1837.
105. Stroh C, Cassens U, Samraj AK, et al. The role of caspases in cryoinjury: Caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells. FASEB J 2002;16:1651-1653.
106. Xu X, Cowley S, Flaim CJ, et al. The roles of apoptotic pathways in the low recovery rate after cryopreservation of dissociated human embryonic stem cells. Biotechnol Prog 2010;26:827-837.
107. Kakkar P, Singh BK., Mitochondria: A hub of redox activities and cellular distress control. Mol Cell Biochem 2007;305:235-253.
108. Mates JM, Segura JA, Alonso FJ, Marquez J. Intracellular redox status and oxidative stress: Implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 2008;82:273-299.
109. Wang AW, Zhang H, Ikemoto I, Anderson DJ, Loughlin KR. Reactive oxygen species generation by seminal cells during cryopreservation. Urology 1997;49:921-925.
110. Chatterjee S, Gagnon C. Production of reactive oxygen species by spermatozoa undergoing cooling, freezing, and thawing. Mol Reprod Devel 2001;59:451-458.
111. Gonzalvez F, Pariselli F, Dupaigne P, et al. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Different 2005;12:614-626.
112. Fowke KR, Behnke J, Hanson C, Shea K, Cosentino LM. Apoptosis: A method for evaluating the cryopreservation of whole blood and peripheral blood mononuclear cells. J Immunol Methods 2000;244:139-144.
113. Martin H, Bournique B, Sarsat JP, Albaladejo V, Lerche- Langrand C. Cryopreserved rat liver slices: A critical evaluation of cell viability, histological integrity, and drugmetabolizing enzymes. Cryobiology 2000;41:135-144.
114. Abrahamsen JF, Bakken AM, Bruserud O, Gjertsen BT. Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases. BoneMarrow Transplant 2002;29:165-171.
115. Slee EA, Zhu H, Chow SC, et al. Benzyloxycarbonyl- Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochemical J 1996;315:21-24.
116. Garcia-Calvo M, Peterson EP, Leiting B, et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998;273:32608-32613.
117. Fujita R, Hui T, Chelly M, Demetriou AA. The effect of antioxidants and a caspase inhibitor on cryopreserved rat hepatocytes. Cell Transplant 2005;14:391-396.
118. Seo JM, Sohn MY, Suh JS, et al. Cryopreservation of amniotic fluid-derived stem cells using natural cryoprotectants and low concentrations of dimethylsulfoxide. Cryobiology 2011;62:167-173.
119. Heng BC, Clement MV, Cao T. Caspase inhibitor Z-VADFMK enhances the freeze-thaw survival rate of human embryonic stem cells. Biosci Rep 2007;27:257-264.
120. Yagi T, Hardin JA, Valenzuela YM, et al. Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes. Hepatology 2001;33:1432-1440.
121. Ko LJ, Prives C. p53: Puzzle and paradigm. Genes Devel 1996;10:1054-1072.
122. Ortega Ferrusola C, Gonzalez Fernandez L, Salazar Sandoval C, et al. Inhibition of the mitochondrial permeability transition pore reduces "apoptosis like" changes during cryopreservation of stallion spermatozoa. Theriogenology 2010;74:458-465.
123. Omori K, Valiente L, Orr C, et al. Improvement of human islet cryopreservation by a p38 MAPK inhibitor. Am J Transplant 2007;7:1224-1232.
124. Hashimoto N, Takeyoshi I, Yoshinari D, et al. Effects of a p38 mitogen-Activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation. Transplantation 2002;74:320-326.
125. Liu K, Yang Y, Mansbridge J. Comparison of the stress response to cryopreservation in monolayer and three-dimensional human fibroblast cultures: Stress proteins, MAP kinases, and growth factor gene expression. Tissue Engineering 2000;6:539-554.
126. Greenway SC, Storey KB. Activation of mitogenactivated protein kinases during natural freezing and thawing in the wood frog. Mol Cell Biochem 2000;209:29-37.
127. Franklin-Tong VE, Gourlay CW. A role for actin in regulating apoptosis/programmed cell death: Evidence spanning yeast, plants and animals. Biochem J 2008;413:389-404.
128. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochemical J 2000;348:241-255.
129. Rizoli SB, Rotstein OD, Parodo J, Phillips MJ, Kapus A. Hypertonic inhibition of exocytosis in neutrophils: Central role for osmotic actin skeleton remodeling. Am J Physiol Cell Physiol 2000;279:C619-633.
130. Reinehr R, Haussinger D. Hyperosmotic activation of the CD95 death receptor system. Acta Physiol (Oxf) 2006;187: 199-203.
131. Aznar S, Lacal JC. Rho signals to cell growth and apoptosis. Cancer Lett 2001;165:1-10.
132. Coleman ML, Olson MF. Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Different 2002;9:493-504.
133. Leverrier Y, Ridley AJ. Apoptosis: Caspases orchestrate the ROCK 'n' bleb. Nature Cell Biol 2001;3:E91-93.
134. Amano M, Chihara K, Kimura K, et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997;275:1308-1311.
135. Leung T, Chen XQ, Manser E, Lim L. The p160 RhoAbinding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 1996;16:5313-5327.
136. Maekawa M, Ishizaki T, Boku S, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999;285:895-898.
137. Di Ciano-Oliveira C, Thirone AC, Szaszi K, Kapus A. Osmotic stress and the cytoskeleton: The R(h)ole of Rho GTPases. Acta Physiol (Oxf) 2006;187:257-272.
138. Piazzolla D, Meissl K, Kucerova L, Rubiolo C, Baccarini M. Raf-1 sets the threshold of Fas sensitivity by modulating Rok-Alpha signaling. J Cell Biol 2005;171:1013-1022.
139. Gauthaman K, Fong CY, Bongso A. Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: Its benefits in hESC expansion. Stem Cell Rev 2010;6:86-95.
140. Krawetz RJ, Li X, Rancourt DE. Human embryonic stem cells: Caught between a ROCK inhibitor and a hard place. BioEssays 2009;31:336-343.
141. Li X, Krawetz R, Liu S, Meng G, Rancourt DE. ROCK inhibitor improves survival of cryopreserved serum/feeder- free single human embryonic stem cells. Hum Reprod 2009;24:580-589.
142. Li X, Meng G, Krawetz R, Liu S, Rancourt DE. The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation. Stem Cells Devel 2008;17:1079-1085.
143. Martin-Ibanez R, Unger C, Stromberg A, et al. Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum Reprod 2008;23:2744-2754.
144. Pakzad M, Totonchi M, Taei A, et al. Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Rev 2010;6:96-107.
145. Watanabe K, Ueno M, Kamiya D, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nature Biotechnol 2007;25:681-686.
146. Claassen DA, Desler MM, Rizzino A. ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Mol Reprod Devel 2009;76:722-732.
147. Heng BC. Effect of Rho-Associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue Cell 2009;41:376-380.
148. Cortes JL, Sanchez L, Ligero G, et al. Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos. Hum Reprod 2009;24:1844-1851.
149. Bueno C, Montes R, Menendez P. The ROCK inhibitor Y- 27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34 + hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34 + HSPCs. Stem Cell Rev 2010;6:215-223.
150. Barbaric I, Jones M, Buchner K, Baker D, et al. Pinacidil enhances survival of cryopreserved human embryonic stem cells. Cryobiology 2011;63:298-305.
151. Sablina AA, Budanov AV, Ilyinskaya GV, et al. The antioxidant function of the p53 tumor suppressor. Nature Med 2005;11:1306-1313.
152. Gallardo BJ, Miró MÁ, Balao SC, et al. Autophagy and apoptosis have a role in the survival or death of stallion spermatozoa during conservation in refrigeration. PloS One 2012;7:e30688.
153. Minor T, Stegemann J, Hirner A, Koetting M. Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning. Liver Transplant 2009;15:798-805.
154. Campbell LH, Taylor MJ, Brockbank K.G. Development of pancreas storage solutions: Initial screening of cytoprotective supplements for b-cell survival and metabolic status after hypothermic storage. Biopreserv Biobanking 2013;11:12-18.